Clinical Trials Logo

Colitis Ulcerative Exacerbation clinical trials

View clinical trials related to Colitis Ulcerative Exacerbation.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT03101800 Recruiting - Colitis, Ulcerative Clinical Trials

Beneficial and Harmful Effects of Azathioprine and Allopurinol Versus Standard Azathioprine Therapy for Patients With Ulcerative Colitis

Start date: December 14, 2016
Phase: Phase 3
Study type: Interventional

Azathioprine is considered first line immunomodulatory therapy for patients with ulcerative colitis. Up to 50% are treatment failures or experience adverse events leading to treatment withdrawal. Recent evidence suggests that the combination of allopurinol and low dose azathioprine increases the proportion of treatment responders and reduce the risk of adverse events. Objectives: To evaluate the beneficial and harmful effects of low dose azathioprine and allopurinol versus standard azathioprine monotherapy in patients with ulcerative colitis.